CoChat

The genomic landscape of cutaneous melanoma

Zhang, Tongwu, Dutton‐Regester, Ken, Brown, Kevin M., Hayward, Nicholas K. · 2016 · Pigment Cell & Melanoma Research
Cited by 172

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Abstract

Summary: Somatic mutation analysis of melanoma has been performed at the single gene level extensively over the past several decades. This has provided considerable insight into the critical pathways controlling melanoma initiation and progression. During the last 5 yr, next‐generation sequencing (NGS) has enabled even more comprehensive mutational screening at the level of multigene panels, exomes and genomes. These studies have uncovered many new and unexpected players in melanoma development. The recent landmark study from The Cancer Genome Atlas (TCGA) consortium describing the genomic architecture of 333 cutaneous melanomas provides the largest and broadest analysis to date on the somatic aberrations underlying melanoma genesis. It thus seems timely to review the mutational landscape of melanoma and highlight the key genes and cellular pathways that appear to drive this cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/pcmr.12459

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • Mutations of the BRAF gene in human cancer

    Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674 · cited 2×

    “The discovery of frequent BRAF mutations in melanomas (Davies et al., 2002) and melanocytic nevi (Pollock et al., 2003) provided the initial opportunity to search for genetic differences between tumors arising on skin with or without evidence of chronic sun damage (based on the presence or absence…”
    Background
  • Signatures of mutational processes in human cancer

    Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660 · cited 3×

    “An alternative approach to separate tumors into subgroups with potentially different UVR exposure patterns is assessment of the proportion of mutations within a tumor that could be ascribed to UVR mutagenesis, for example C>T or CC>TT mutations, or perhaps more precisely in the context of a mutational signature based…”
    Background
  • Mutational heterogeneity in cancer and the search for new cancer-associated genes

    Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461

  • Genomic classification of cutaneous melanoma

    Akbani, R., Akdemir, K. C., Aksoy, B. A., Albert, M., Ally, A., Amin, S. B., Arachchi, H., Arora, A., Auman, J. T., Ayala, B., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.044 · Cited by 3,151 · cited 21×

    “An imperfect surrogate for UVR exposure that can be evaluated in most datasets is body site of primary tumor and is available for a subset of the TCGA melanomas (Watson et al., 2015).”
    BackgroundResultInfluentialSelf-citation
  • Discovery and saturation analysis of cancer genes across 21 tumour types

    Lawrence, M. S., Stojanov, P., Mermel, C. H., Robinson, J. T., Garraway, L. A., Golub, T. R., Meyerson, M., Gabriel, S. B., Lander, E. S., & Getz, G. (2014) · Nature · doi:10.1038/nature12912 · Cited by 3,096

  • Genomic correlates of response to CTLA-4 blockade in metastatic melanoma

    Van Allen, E. M., Miao, D., Schilling, B., Shukla, S. A., Blank, C., Zimmer, L., Sucker, A., Hillen, U., Geukes Foppen, M. H., Goldinger, S. M., et al. (2015) · Science · doi:10.1126/science.aad0095 · Cited by 2,839 · cited 1×

    “High somatic mutation burden in melanoma has already been linked to favorable outcomes of immune-based therapeutic approaches using CTLA-4 antibodies (Snyder et al., 2014; Van Allen et al., 2015).”
    Background
  • A cell cycle regulator potentially involved in genesis of many tumor types

    Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751

  • Distinct Sets of Genetic Alterations in Melanoma

    Curtin, J. A., Fridlyand, J., Kageshita, T., Patel, H. N., Busam, K. J., Kutzner, H., Cho, K.-H., Aiba, S., Bröcker, E.-B., LeBoit, P. E., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050092 · Cited by 2,747

  • A landscape of driver mutations in melanoma

    Hodis, E., Watson, I. R., Kryukov, G. V., Arold, S. T., Imielinski, M., Theurillat, J.-P., Nickerson, E., Auclair, D., Li, L., Place, C., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.024 · Cited by 2,610 · cited 15×

    “…number of melanomas included 121 tumors and introduced a statistical approach to identify SMGs based on predicted functional impact of the mutations as well as ‘local’ mutation rate (i.e. relative abundance of mutations between exons and introns/UTRs of the same gene) (Hodis et al., 2012).”
    BackgroundMethodResultInfluential
  • TERT Promoter Mutations in Familial and Sporadic Melanoma

    Horn, S., Figl, A., Rachakonda, P. S., Fischer, C., Sucker, A., Gast, A., Kadel, S., Moll, I., Nagore, E., Hemminki, K., et al. (2013) · Science · doi:10.1126/science.1230062 · Cited by 1,799 · cited 5×

    “…comes from a simultaneous report of both germline and somatic TERT promoter mutations in melanomas, in which two additional recurrent tandem GG>AA (CC>TT) somatic mutations generating ETS binding sites were reported at positions chr5:1295228/ 1295229 and chr5:1295242/1295243 (Horn et al., 2013).”
    BackgroundResultInfluential

Show all 30 references

Cited by

Metadata

Authors
Zhang, T., Dutton‐Regester, K., Brown, K. M., & Hayward, N. K.
Venue
Pigment Cell & Melanoma Research
Publisher
Wiley
Published
2016-03-04
Volume
29
Issue
3
Pages
266-283
ISSN
  • 1755-1471 (ISSN-L)
  • 1755-148X
OpenAlex
W2294698383
Cited by
172
References
30
FWCI
10.53
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.